Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 9/20 | 0.34 |
| ▸ | HCRTR2 | O43614 | 9/20 | 0.34 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | MPO | P05164 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | AKT1 | P31749 | 2/20 | 0.31 |
| ▸ | HTR2A | P28223 | 3/20 | 0.31 |
| ▸ | HTR7 | P34969 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31479447 | 0.88 | HCRTR1 (0.34) | HCRTR1HCRTR2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL31479275 | 0.81 | HCRTR1 (0.39) | HCRTR1HCRTR2PTGDR2 | |
| SCHEMBL31478928 | 0.81 | TRPV3 (0.40) | — | |
| SCHEMBL31479117 | 0.81 | SLC6A2 (0.35) | HCRTR1HCRTR2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL31479460 | 0.80 | SLC6A2 (0.35) | HCRTR1HCRTR2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL31479110 | 0.80 | SLC6A2 (0.35) | HCRTR1HCRTR2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL31479544 | 0.80 | SLC6A2 (0.35) | HCRTR1HCRTR2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL31479231 | 0.78 | MEN1 (0.49) | KCNH2MEN1KMT2AHTR2AHTR7 | |
| SCHEMBL31479425 | 0.75 | MAPK1 (0.36) | SLC6A2SLC6A4SLC6A3KCNH2AKT1 | |
| SCHEMBL31479670 | 0.75 | HCRTR1 (0.36) | HCRTR1HCRTR2KCNH2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025067111-A1 | MENIN-MLL INTERACTION INHIBITOR AND PREPARATION METHOD THEREFOR, AND APPLICATION | 苏州必扬医药科技有限公司 | 2025-04-03 | — | — | WO | disclosed |